iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Lincoln National Corp

Lincoln National Corp cut its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 14.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,233 shares of the financial services provider’s stock after selling 1,398 shares during the quarter. Lincoln National Corp’s holdings in iShares Biotechnology ETF were worth $1,118,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in the company. SYM FINANCIAL Corp lifted its stake in iShares Biotechnology ETF by 236.2% during the 4th quarter. SYM FINANCIAL Corp now owns 427 shares of the financial services provider’s stock valued at $58,000 after acquiring an additional 300 shares during the period. Avidian Wealth Solutions LLC acquired a new position in iShares Biotechnology ETF during the fourth quarter valued at $302,000. TCG Advisory Services LLC purchased a new stake in iShares Biotechnology ETF in the fourth quarter valued at $268,000. Axxcess Wealth Management LLC grew its position in iShares Biotechnology ETF by 55.3% during the 4th quarter. Axxcess Wealth Management LLC now owns 6,486 shares of the financial services provider’s stock worth $881,000 after purchasing an additional 2,310 shares during the period. Finally, First Horizon Advisors Inc. boosted its stake in shares of iShares Biotechnology ETF by 5.5% in the fourth quarter. First Horizon Advisors Inc. now owns 2,193 shares of the financial services provider’s stock worth $298,000 after buying an additional 115 shares during the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Down 0.5 %

Shares of iShares Biotechnology ETF stock opened at $132.59 on Thursday. iShares Biotechnology ETF has a fifty-two week low of $111.83 and a fifty-two week high of $141.16. The firm has a 50-day simple moving average of $133.20 and a two-hundred day simple moving average of $130.36.

iShares Biotechnology ETF Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Friday, March 22nd were paid a dividend of $0.126 per share. The ex-dividend date was Thursday, March 21st. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.38%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.